US 7910587
Quinoxalinyl dipeptide hepatitis C virus inhibitors
granted A61KA61K38/21A61P
Quick answer
US patent 7910587 (Quinoxalinyl dipeptide hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/21, A61P, A61P31/12